Distillate Capital Partners
ELAN icon

Distillate Capital Partners’s Elanco Animal Health ELAN Stock Holding History

Distillate Capital Partners’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-48,127
Closed -$1.45M – 122
2020
Q4 		$1.45M Buy
+48,127
New +$1.47M 0.69% 89

Other funds holding ELAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Sachem Head Capital Management
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Amundi Asset Management US
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Distillate Capital Partners's ELAN Position: Q1 2021 in Review

Distillate Capital Partners sold out of Elanco Animal Health (ELAN) in Q1 2021, closing a stake of 48,127 shares — an estimated $1.45M sold.

Distillate Capital Partners first reported a position in ELAN in Q4 2020 and held it in 1 quarter. The position peaked at $1.45M in Q4 2020. 450 funds tracked by Wall St. Rank hold ELAN as of Q1 2021.

  • Distillate Capital Partners reported no remaining Elanco Animal Health position as of Q1 2021 after selling out during the quarter.
  • Distillate Capital Partners sold 48,127 Elanco Animal Health shares in Q1 2021, an estimated $1.45M.
  • Distillate Capital Partners first reported a position in Elanco Animal Health in Q4 2020 and held it in 1 quarter.
  • Distillate Capital Partners's Elanco Animal Health position peaked at $1.45M in Q4 2020.
  • 450 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2021.

Based on Distillate Capital Partners's 13F filing for Q1 2021, filed 13 May 2021.